Skip to main content

Advertisement

Log in

Molecular Screening for 22Q11.2 Deletion Syndrome in Patients With Congenital Heart Disease

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Few studies have investigated the prevalence of 22q11.2 deletion syndrome (22q11.2DS) among patients with isolated heart defects or nonconotruncal heart defects. Polymerase chain reaction (PCR) followed by length polymorphism restriction fragment analysis (RFLP) is useful for low-cost molecular diagnosis and screening. This cross-sectional study included 392 patients with congenital heart disease, described clinical features, and performed PCR–RFLP for analysis of polymorphism in three loci with a high heterozygosity rate located in the typically deleted region of 1.5 megabases. Heterozygosity excluded 22q11.2DS. Patients with homozygosity for the three markers underwent multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH) for the final diagnosis, estimating the prevalence of 22q11.2DS. The use of PCR–RFLP excluded 22q11.2DS in 81.6 % (n = 320) of 392 patients. Of the remaining 72 patients, 65 underwent MLPA, showing 22q11.2DS in five cases (prevalence, 1.27 %). Four of these five patients underwent FISH, confirming the MLPA results. All five patients with the deletion had heart diseases commonly found with 22q11.2DS (interrupted aortic arch, persistent truncus arteriosus, tetralogy of Fallot, and ventricular septal defect plus atrial septal defect). Two patients had congenital extracardiac anomaly (one with arched palate and micrognathia and one with hypertelorism). Three patients reported recurrent respiratory infections, and one patient reported hypocalcemia. All were underweight or short in stature for their age. This study contributed to showing the prevalence of 22q11.2DS in patients with any congenital heart disease, with or without other features of the syndrome. Patients with 22q11.2DS may not have all the major features of the syndrome, and those that are found may be due to the heart defect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Amati F, Conti E, Novelli A et al (1999) Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome. Eur J Hum Genet 7:903–909

    Article  CAS  PubMed  Google Scholar 

  2. Botto LD, May K, Fernhoff PM et al (2003) A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112:101–107

    Article  PubMed  Google Scholar 

  3. Brauner R, Le Harivel de Gonneville A, Kindermans C et al (2003) Parathyroid function and growth in 22q11.2 deletion syndrome. J Pediatr 142:504–508

  4. Chegar BE, Tatum SA, Marrinan E, Shprintzen RJ (2006) Upper airway asymmetry in velo-cardio-facial syndrome. Int J Pediatr Otorhinolaryngol 70:1375–1381

    Article  PubMed  Google Scholar 

  5. Chen YF, Kou PL, Tsai SJ et al (2006) Computational analysis and refinement of sequence structure on chromosome 22q11.2 region: application to the development of quantitative real-time PCR assay for clinical diagnosis. Genomics 87:290–297

    Article  CAS  PubMed  Google Scholar 

  6. Debbané M, Glaser B, David MK, Feinstein C, Eliez S (2006) Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications. Schizophr Res 84:187–193

    Article  PubMed  Google Scholar 

  7. Driscoll DA (1994) Genetic basis of DiGeorge and velocardiofacial syndromes. Curr Opin Pediatr 6:702–706

    Article  CAS  PubMed  Google Scholar 

  8. Driscoll DA, Emanuel BS, Mitchell LE, Budarf ML (1997) PCR assay for screening patients at risk for 22q11.2 deletion. Genet Test 1:109–113

    Article  CAS  PubMed  Google Scholar 

  9. Eirís-Puñal J, Iglesias-Meleiro JM, Blanco-Barca MO et al (2003) Phenotypic variability of deletion 22q11.2: an analysis of 16 observations with special emphasis on the neurological manifestations. Rev Neurol 37:601–607 (in Spanish)

    PubMed  Google Scholar 

  10. Fernández L, Lapunzina P, Arjona D et al (2005) Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndrome. Clin Genet 68:373–378

    Article  PubMed  Google Scholar 

  11. Funke BH, Brown AC, Ramoni MF et al (2007) A novel, single-nucleotide polymorphism-based assay to detect 22q11 deletions. Genet Test 11:91–100

    Article  CAS  PubMed  Google Scholar 

  12. Gawde H, Patel ZM, Khatkhatey MI et al (2006) Chromosome 22 microdeletion by FISH in isolated congenital heart disease. Indian J Pediatr 73:885–888

    Article  CAS  PubMed  Google Scholar 

  13. Gerdes M, Solot C, Wang PP et al (1999) Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet 85:127–133

    Article  CAS  PubMed  Google Scholar 

  14. Gioli-Pereira L, Pereira AC, Mesquita SM, Lopes AA, Krieger JE (2006) PCR screening for 22q11.2 microdeletion: development of a new cost-effective diagnostic tool. Clin Chim Acta 369:78–81

    Article  CAS  PubMed  Google Scholar 

  15. Gitai DL, Romcy-Pereira RN, Gitai LL, Leite JP, Garcia-Cairasco N, Paco-Larson ML (2008) Genes and epilepsy I: epilepsy and genetic alterations. Rev Assoc Med Bras 54:272–278 (in Portuguese)

    Article  PubMed  Google Scholar 

  16. Goodship J, Cross I, LiLing J, Wren C (1998) A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 79:348–351

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Greenhalgh KL, Aligianis IA, Bromilow G et al (2003) 22q11 Deletion: a multisystem disorder requiring multidisciplinary input. Arch Dis Child 88:523–524

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Halder A, Jain M, Kabra M, Gupta N (2008) Mosaic 22q11.2 microdeletion syndrome: diagnosis and clinical manifestations of two cases. Mol Cytogenet 1:18

    Article  PubMed Central  PubMed  Google Scholar 

  19. Kariyazono H, Ohno T, Ihara K et al (2001) Rapid detection of the 22q11.2 deletion with quantitative real-time PCR. Mol Cell Probes 15:71–73

    Article  CAS  PubMed  Google Scholar 

  20. Kuczmarski RJ, Ogden CL, Guo SS et al (2002) 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11:1–190

    Google Scholar 

  21. Lahiri DK, Nurnberger JI Jr (1991) A rapid nonenzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Maharasingam M, Ostman-Smith I, Pike MG (2003) A cohort study of neurodevelopmental outcome in children with DiGeorge syndrome following cardiac surgery. Arch Dis Child 88:61–64

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. McDonald-McGinn DM, Kirschner R, Goldmuntz E et al (1999) The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 10:11–24

    CAS  PubMed  Google Scholar 

  24. Moreno Izco F, Zuazo Zamalloa E, González Alvaredo S, Bereciartu Irastorza P (2009) 22q11 Deletion syndrome: an expanding phenotype. Neurologia 24:69–71 (in Spanish)

    CAS  PubMed  Google Scholar 

  25. Payne RM, Johnson MC, Grant JW, Strauss AW (1995) Toward a molecular understanding of congenital heart disease. Circulation 91:494–504

    Article  CAS  PubMed  Google Scholar 

  26. Pereira AC, Corrêa RF, Mota GF, Kim CA, Mesquita SF, Krieger JE (2003) High-specificity PCR screening for 22q11.2 microdeletion in three different ethnic groups. Braz J Med Biol Res 36:1359–1365

    Article  CAS  PubMed  Google Scholar 

  27. Rauch A, Zink S, Zweier C et al (2005) Systematic assessment of atypical deletions reveals genotype–phenotype correlation in 22q11.2. J Med Genet 42:871–876

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Rosa RF, Pilla CB, Pereira VL et al (2008) 22q11.2 Deletion syndrome in patients admitted to a cardiac pediatric intensive care unit in Brazil. Am J Med Genet A 146A:1655–1661

    Article  PubMed  Google Scholar 

  29. Ryan AK, Goodship JA, Wilson DI et al (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34:798–804

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Scambler PJ (2000) The 22q11 deletion syndromes. Hum Mol Genet 9:2421–2426

    Article  CAS  PubMed  Google Scholar 

  31. Schaan BD, Huber J, Leite JC, Kiss A (2006) Cardiac surgery unmasks latent hypoparathyroidism in a child with the 22q11.2 deletion syndrome. J Pediatr Endocrinol Metab 19:943–946

    Article  PubMed  Google Scholar 

  32. Shaikh TH, O’Connor RJ, Pierpont ME et al (2007) Low copy repeats mediate distal chromosome 22q11.2 deletions: sequence analysis predicts breakpoint mechanisms. Genome Res 17:482–491

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Stachon AC, Baskin B, Smith AC et al (2007) Molecular diagnosis of 22q11.2 deletion and duplication by multiplex ligation dependent probe amplification. Am J Med Genet A 143A:2924–2930

    Article  PubMed  Google Scholar 

  34. Van Aken K, De Smedt B, Van Roie A et al (2007) Motor development in school-aged children with 22q11 deletion (velocardiofacial/DiGeorge syndrome). Dev Med Child Neurol 49:210–213

    Article  PubMed  Google Scholar 

  35. Vervoordeldonk SF, Doumaid K, Remmerswaal EB et al (1998) Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion. Br J Haematol 102:1004–1009

    Article  CAS  PubMed  Google Scholar 

  36. Vorstman JA, Jalali GR, Rappaport EF, Hacker AM, Scott C, Emanuel BS (2006) MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum Mutat 27:814–821

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Widdershoven JC, Beemer FA, Kon M, Dejonckere PH, Mink van der Molen AB (2008) Possible mechanisms and gene involvement in speech problems in the 22q11.2 deletion syndrome. J Plast Reconstr Aesthet Surg 61:1016–1023

    Article  CAS  PubMed  Google Scholar 

  38. Wozniak A, Wolnik-Brzozowska D, Wisniewska M et al (2010) Frequency of 22q11.2 microdeletion in children with congenital heart defects in western Poland. BMC Pediatr 10:88

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

The acknowledge the contributions of Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS), Centro Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundo de Apoio à Pesquisa do Instituto de Cardiologia/Fundação Universitária de Cardiologia à Ciência e à Cultura (FAPICC), Fundo de Incentivo à Pesquisa e Eventos/Hospital de Clínicas de Porto Alegre (FIPE-HCPA), and RedeBRIM Project/Centro Nacional de Desenvolvimento Científico e Tecnológico (CNPq)/Brazil.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lucia Campos Pellanda.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huber, J., Peres, V.C., de Castro, A.L. et al. Molecular Screening for 22Q11.2 Deletion Syndrome in Patients With Congenital Heart Disease. Pediatr Cardiol 35, 1356–1362 (2014). https://doi.org/10.1007/s00246-014-0936-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-014-0936-0

Keywords

Navigation